Bethany Karl is a Nephrology physician affiliated with University of California San Diego. OpenAlex indexes 10 publications with 644 citations (h-index 3); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Directed Use of REmote Patient Management System AMia to Achieve Prescribed Dry Weight
Sponsor: University of California, San Diego
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
45.4%Calcium channel blocker12.8%Amlodipine Besylate52%Nifedipine Er48%Part D≥29 patientsAngiotensin receptor blocker (ARB)7.2%Losartan Potassium63%Valsartan37%Part D<11 patients+ 7 more classes in this area
Metabolism & gastrointestinal
31.9%SGLT2 inhibitor10.8%Farxiga66%Jardiance22%Invokana12%Part D<11 patientsVitamin D3 Analog9.8%Calcitriol100%Part D≥25 patients+ 6 more classes in this area
Other
8.5%Phosphate Binder6%Sevelamer Carbonate100%Part D≥16 patientsDrugs for treatment of hyperkalemia and hyperphosphatemia2.5%Lanthanum Carbonate50%Velphoro50%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Jay Giedd, MD
University of California San Diego
Robert Weinreb, MD
University of California San Diego
Dilip Jeste, MD
University of California San Diego
Igor Grant, MD
University of California San Diego
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”